FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients
<!-- Name:DistributionId Value:8843724 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…